IceCure at SBI 2026 Symposium: Discover ProSense® Cryoablation for Breast Tumors

Visit us at Booth 817 during the SBI Breast Imaging Symposium to explore cryoablation for low-risk breast cancers and fibroadenoma.

Cryoablation Allows the Ultimate De-escalation of Surgical Therapy for Select Breast Cancer Patients

A study showing that cryoablation allows the ultimate de-escalation of surgical therapy for select breast cancer patients.

Assessing the Outcome of Cryoablation Treatment on Different Molecular Subtypes of Low-Grade Breast Cancer

Study assessing the outcome of cryoablation treatment on different molecular subtypes of low-grade breast cancer.

Cryoablation of Primary Breast Cancer in Patients Ineligible for Clinical Trials: A Multiinstitutional Study

Study on the cryoablation of primary breast cancer in patients ineligible for clinical trials: a multi-institutional study.

Cryoablation Therapy for Early-Stage Breast Cancer: Evidence and Rationale

This publication provides a comprehensive evaluation of cryoablation as a non-surgical alternative to traditional breast-conserving surgery for early-stage breast cancer.

Percutaneous Ultrasound-Guided Cryoablation for Early-Stage Primary Breast Cancer: A Follow-Up Study in Japan

The study investigates the long-term outcomes of percutaneous cryoablation (PCA) as a minimally invasive treatment for early-stage breast cancer (ESBC).

IceCure to Exhibit at the 2024 American Society of Breast Surgeons (ASBrS) Annual Meeting in Orlando, Florida

IceCure Medical  is excited to announce our participation in the 26 Annual Meeting of The American Society of Breast Surgeons (ASBrS), happening April 10 – 14 at Marriott Orlando World Center, Orlando Florida. This event presents a prime opportunity for experts to discover the innovative ProSense System for breast tumor cryoablation. We invite you to […]